Generated by GPT-5-mini| M.D. Anderson | |
|---|---|
| Name | The University of Texas MD Anderson Cancer Center |
| Caption | Main building, Houston, Texas |
| Location | Houston, Texas |
| Country | United States |
| Type | Cancer hospital |
| Specialty | Oncology |
| Founded | 1941 |
| Affiliation | University of Texas |
| Beds | 670 |
M.D. Anderson
The University of Texas MD Anderson Cancer Center is a comprehensive cancer center in Houston, Texas, dedicated to patient care, research, education, and prevention. Founded with a mission to eliminate cancer, it is affiliated with the University of Texas system and is part of the Texas Medical Center alongside institutions such as Baylor College of Medicine, Texas Children's Hospital, Houston Methodist, Saint Luke's Episcopal Hospital, and Memorial Hermann–Texas Medical Center. The center collaborates with national and international organizations including the National Cancer Institute, American Cancer Society, World Health Organization, National Institutes of Health, and Cancer Research UK.
The center was established in 1941 during the tenure of leaders influenced by figures like Theodore Roosevelt Jr. and philanthropic entities including the Rothschild family and the Rockefeller Foundation. Early directors worked with scholars from Harvard Medical School, Johns Hopkins Hospital, Mayo Clinic, Massachusetts General Hospital, and UCLA Health to build clinical and research programs. Throughout the Cold War era the institution expanded amid federal initiatives led by the National Cancer Act of 1971 and partnerships with agencies such as the Department of Defense and the Mutual Defense Assistance Act for radiation and chemotherapy research. Notable administrative figures promoted collaborations with leaders from Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, Fred Hutchinson Cancer Research Center, and Sloan-Kettering Institute to develop translational pipelines. In recent decades the center has engaged with multinational trials involving groups like EORTC, SWOG, Alliance for Clinical Trials in Oncology, and Children's Oncology Group.
The main campus sits in the Texas Medical Center district of Houston near Hermann Park and the Houston Museum District. Facilities include inpatient towers, outpatient clinics, infusion centers, and specialized units adjacent to institutions such as University of Texas Health Science Center at Houston and Rice University. Research buildings host core labs originally modeled on infrastructure at Brookhaven National Laboratory, Lawrence Berkeley National Laboratory, and Argonne National Laboratory. The campus houses imaging centers with MRI and PET/CT suites comparable to installations at Cleveland Clinic and Johns Hopkins Medicine, as well as proton therapy and radiation facilities similar to those at Massachusetts General Hospital and The Christie Hospital. Patient amenities and support services are coordinated with local partners including Houston Community College, Harris County Hospital District, and civic organizations like the Greater Houston Partnership.
The center conducts multidisciplinary research across basic, translational, and clinical domains, collaborating with investigators from institutions such as Stanford University, Columbia University, University of Pennsylvania, Princeton University, and Yale University. Research programs encompass genomics initiatives linked to projects like the Human Genome Project, precision oncology alliances with Foundation Medicine, immunotherapy trials inspired by work at Parker Institute for Cancer Immunotherapy, CAR T-cell collaborations informed by studies at University of Pennsylvania, and targeted therapy programs aligned with discoveries from Broad Institute and Cold Spring Harbor Laboratory. Clinical trials are coordinated with regulatory agencies including the Food and Drug Administration and international networks like International Agency for Research on Cancer. Major disease-focused programs address malignancies such as breast cancer, lung cancer, colorectal cancer, hematologic malignancies, and pediatric cancers, partnering with specialty centers like St. Jude Children's Research Hospital and Children's Hospital of Philadelphia.
Patient care integrates medical oncology, surgical oncology, radiation oncology, and supportive services. Multidisciplinary tumor boards include specialists trained at Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, UCLA Health, Mayo Clinic, and Cleveland Clinic. Services encompass chemotherapy infusions, surgical oncology procedures comparable to those at Mount Sinai Hospital, radiation therapy including stereotactic radiosurgery akin to programs at Barrow Neurological Institute, palliative and hospice coordination with organizations like Hospice Care of Texas, and survivorship programs modeled on efforts at City of Hope. Patient navigation, genetic counseling, and psychosocial support are offered in collaboration with advocacy groups such as Susan G. Komen, Leukemia & Lymphoma Society, and American Society of Clinical Oncology.
The center provides residency and fellowship programs in partnership with University of Texas Medical Branch, Baylor College of Medicine, and national certifying organizations like the Accreditation Council for Graduate Medical Education and the American Board of Internal Medicine. Training spans oncology fellowships, nursing education linked to Johns Hopkins School of Nursing, advanced practice provider programs, and postdoctoral research fellowships comparable to those at National Institutes of Health. Continuing medical education events attract speakers from American Society of Hematology, European Society for Medical Oncology, Society for Immunotherapy of Cancer, and global academic centers including Karolinska Institutet and University of Oxford.
The center has received recognition from ranking bodies and award organizations such as U.S. News & World Report, the National Cancer Institute, the Association of American Medical Colleges, and philanthropic awards associated with foundations like The Robert Wood Johnson Foundation. Its clinical trial outputs and publications appear in journals including The New England Journal of Medicine, The Lancet, Journal of Clinical Oncology, Nature Medicine, and Science Translational Medicine. International collaborations extend to partners like Imperial College London, Peking University, University of Tokyo, and Instituto Nacional de Cancerología, contributing to global oncology guidelines issued by entities such as the World Health Organization and professional societies including American Society of Clinical Oncology.
Category:Cancer hospitals Category:Hospitals in Houston